(NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has expanded its reimbursement approval of the company’s PainShield™ product by adding the device to its Durable Medical Equipment (DME) schedule. Effective immediately, PainShield is reimbursable as an approved medical device under a unique reimbursement code assigned by CMS for low frequency ultrasonic diathermy treatment specifically for home use. The product is currently the only device approved for reimbursement under the unique HCPCS code K1004, which was established through the company’s efforts and work with CMS. Visit